Aerovate Therapeutics
AVTE
#9167
Rank
A$0.11 B
Marketcap
$4.04
Share price
0.00%
Change (1 day)
-86.86%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$16.72 Million

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are A$16.72 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$12.57 M209.59%
2021-12-31A$4.06 M-82.7%
2020-12-31A$23.48 M129.75%
2019-12-31A$10.22 M